Atossa Therapeutics, Inc. (ATOS)
3.94
-0.11
(-2.72%)
USD |
NASDAQ |
Feb 12, 16:00
3.86
-0.08
(-2.03%)
After-Hours: 20:00
Atossa Therapeutics Market Cap : 33.93M for Feb. 12, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Celldex Therapeutics, Inc. | 1.558B |
| Abeona Therapeutics, Inc. | 270.42M |
| Cell Source, Inc. | 38.28M |
| Kiora Pharmaceuticals, Inc. | 7.65M |
| Intellia Therapeutics, Inc. | 1.346B |
Market Cap Related Metrics
| PEG Ratio | -0.0012 |
| Price to Book Value | 0.6815 |
| Price | 3.94 |
| Earnings Yield | -70.85% |
| PEGY Ratio | -0.0012 |